Dr. Axel Bauer and Dr. C. Michael Gibson Discuss: eBRAVE-AF – Smartphone-based AF screening August 28, 2022 Disclosures: TBA
Dr. Renato Lopes Presents: APOLLO – Apixaban for prophylaxis of thromboembolic outcomes in COVID-19 August 28, 2022 Disclosure: TBA
Dr. Mike Sharma and Dr. C. Michael Gibson Discuss: AXIOMATIC-SSP: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention August 28, 2022 Disclosures: TBA
Dr. Ashkan Shoamanesh and Dr. C. Michael Gibson Discuss: PACIFIC-STROKE – Phase 2 Program of AntiCoagulation via Inhibition of FXIa by the oral Compound BAY 2433334 – non-cardioembolic STROKE study August 28, 2022 Disclosure: TBA
Dr. John Alexander and Dr. C. Michael Gibson Discuss: PACIFIC-AMI – Efficacy and safety of factor XIa inhibitor asundexian on top of dual antiplatelet therapy after acute myocardial infarction August 28, 2022 Disclosure: TBA
Dr. Ganesan Karthikeyan and Dr. C. Michael Gibson Discuss: INVICTUS – Rivaroxaban versus VKA for rheumatic atrial fibrillation August 28, 2022 Disclosures: TBA
Dr. Jacob Eifer Moller Presents: BOX – Oxygen therapy in comatose OHCA patients August 27, 2022 Disclosure: TBA
Dr. Scott Solomon, Dr. Pardeep Jhund, Dr. Muthiah Vaduganathan, and Dr. C. Michael Gibson Discuss: DELIVER – Dapagliflozin in Heart Failure with Mildly Reduced and Preserved Ejection Fraction August 27, 2022 Disclosures: TBA
Dr. Muthiah Vaduganathan Presents: A Pre-Specified Meta-Analysis of DELIVER and EMPEROR-Preserved August 27, 2022 Disclosures: TBA
Dr. David Ouyang Presents: EchoNet-RCT – Safety and Efficacy Study of AI LVEF August 27, 2022 Disclosure: TBA
